Shanghai Haohai Biological Technology Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 5/6
Shanghai Haohai Biological Technology has a total shareholder equity of CN¥6.0B and total debt of CN¥423.7M, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are CN¥7.2B and CN¥1.2B respectively. Shanghai Haohai Biological Technology's EBIT is CN¥404.8M making its interest coverage ratio -6.4. It has cash and short-term investments of CN¥2.7B.
Wichtige Informationen
7.0%
Verhältnis von Schulden zu Eigenkapital
CN¥423.70m
Verschuldung
| Zinsdeckungsgrad | -6.4x |
| Bargeld | CN¥2.69b |
| Eigenkapital | CN¥6.03b |
| Gesamtverbindlichkeiten | CN¥1.21b |
| Gesamtvermögen | CN¥7.25b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 6826's short term assets (CN¥3.7B) exceed its short term liabilities (CN¥861.5M).
Langfristige Verbindlichkeiten: 6826's short term assets (CN¥3.7B) exceed its long term liabilities (CN¥350.6M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 6826 has more cash than its total debt.
Schulden abbauen: 6826's debt to equity ratio has increased from 0.7% to 7% over the past 5 years.
Schuldendeckung: 6826's debt is well covered by operating cash flow (159%).
Zinsdeckung: 6826 earns more interest than it pays, so coverage of interest payments is not a concern.